Ascentage Pharma Group International AAPG
NASDAQ AAPG
$16.34 +0.43 (+2.79%)
As of: Oct 21, 2026 · 2:02 PM EDT

Ascentage Pharma Group International (AAPG) Assets (2023 - 2026)

Updated

Ascentage Pharma Group International (AAPG) recorded Assets of $477.62 million in Q2 2026, up 13.4% from $421.14 million a year earlier.

Analysis

Ascentage Pharma Group International (AAPG) Assets (2023 - 2026) Analysis & Trends

At the end of FY2025, Ascentage Pharma Group International reported Assets of $551.54 million, up 53.8% from FY2024.

  • Across earlier years, Assets came in at $358.64 million in FY2024 (+1.4%) and $353.81 million in FY2023.
  • Quarterly Assets has ranged from $347.27 million in Q4 2023 to $558.84 million in Q4 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 201.06 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 135.12 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 115.83 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 49.36 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 201.13 Bn
10 Ascentage Pharma Group International 1.45 Bn 417.61 Mn - 477.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 477.62 Mn
Dec 31, 2025 566.60 Mn
Jun 30, 2025 425.23 Mn
Dec 31, 2024 358.67 Mn
Dec 31, 2023 351.82 Mn
API Access

Ascentage Pharma Group International Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=AAPG&period=max&api_key=YOUR_API_KEY